{"name":"Hope Medicine (Nanjing) Co., Ltd","slug":"hope-medicine-nanjing-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"HMI-115, 240mg-Q2W","genericName":"HMI-115, 240mg-Q2W","slug":"hmi-115-240mg-q2w","indication":"Other","status":"phase_2"},{"name":"HMI-115-240mg-Q4W","genericName":"HMI-115-240mg-Q4W","slug":"hmi-115-240mg-q4w","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"HMI-115","genericName":"HMI-115","slug":"hmi-115","indication":"Non-small cell lung cancer","status":"phase_3"}]}],"pipeline":[{"name":"HMI-115","genericName":"HMI-115","slug":"hmi-115","phase":"phase_3","mechanism":"HMI-115 is a humanized monoclonal antibody that targets and inhibits PD-L1, blocking its interaction with PD-1 and B7.1 to enhance anti-tumor immune responses.","indications":["Non-small cell lung cancer","Other solid tumors (under investigation)"],"catalyst":""},{"name":"HMI-115, 240mg-Q2W","genericName":"HMI-115, 240mg-Q2W","slug":"hmi-115-240mg-q2w","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"HMI-115-240mg-Q4W","genericName":"HMI-115-240mg-Q4W","slug":"hmi-115-240mg-q4w","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQUkhOY3UxZ3hIcDFCNUt2alVweW1Mb2ZNbnZvSXJkWlF2Z0tfVVV1YU01c281ZjZiTk5uQko4bjF2eHZ3RmowbzUxVFVkTFBIWVpZb25xN01IUjNYZ2NEVnAxdktQZmVPaUJWNUdfQ2xrWmNFQWxqUHgyZlFMbWJXOUplRGw0WjAtN3hWTmU2V3p4X1dfUVVqUXNoNmZjY0lsbmlPSURkUkJWRXdmQ0ozM2diREluUUFubmpuZm43RlpMV0hUWG4zTVE3YkZzYnJpaXNwdWRYWQ?oc=5","date":"2026-03-25","type":"trial","source":"Thailand Business News","summary":"Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - Thailand Business News","headline":"Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPTkRheG11dFNObS1SUFVwcXJXQ1M0QVJpVk1JX2k4VHVKMEJzQTBjQk9GQ0tScWNwUEowXzg0Y3lEQjJKUTlYdjY2Nmd3SUZzVnJSTVk2RmhKSy1oWFk1ZHBIaEQxWU5HRHhFeE15THFwSC1FVmxXZVVuNlZjdWlyMEx6R2dhWXFxalNZRU1fWWNUNENwQmlXanFmcE1yV29lT1EzVmV0ZHFJNzVOQ1ZSaG9lQnVkUEFtS1k4dFQ2bEJoaUwyTUNkWUI2eXFkT1NoMGJLeFhObUlyN04zMUVicTYzSmpYa1FJNC01blBVZGNsTlhMM2lyUzI4SVBjekVwZmNwUWxHUHRVbnB1UnRHdENvS1drSTNkdHpRYkJrSWlPamZmZ2g0d3N3?oc=5","date":"2026-03-12","type":"pipeline","source":"PR Newswire","summary":"Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Treatment Options | DelveInsight - PR Newswire","headline":"Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Tr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPVzA4RksxZlZJNU9QMVRGYXJRekpLUk5Jb3h6Mzk3UDFPem9zSUtzd2RSQllHbDF3LUdjbEJfYWd3UGV2UmhyT2trQWNfUlR5ZDVLVnlXYXB5czFwVG1mRDEyQWhzNEdac2hCWEk4RDl3aGxSMnpVdTA5U1BrSFBmaGZ1cnZ0MVpNVDktZF9xV0J3ZGRIQk1hbUNKZDJMVlNiUTN5Z0NsWGI5U0ZINnJxNnhWaVpocC1kTHdDWnk1Zl9IemhFQWZsbTZkM0FiaC1YZW1YekxOOHBpRWFWbG55MUQ0bXZCd1p3LS01NDg5cXFoY2Q0M3NrUk9yVjQ2YUlDaUhpeFN2b0loaWhiWW44MmdJTEdNTWtFSFNTemNYTkNEekZkWWc?oc=5","date":"2026-01-22","type":"trial","source":"globenewswire.com","summary":"Endometriosis Clinical Trial Pipeline Accelerates as 18+ - globenewswire.com","headline":"Endometriosis Clinical Trial Pipeline Accelerates as 18+","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPRzNBQkhIZmN6MTlDTGF0emtOSFJYaGt3VmpTZ3praWp3dHNwcElZWWctSXFvaER3UEVWMzBXZEJqMDZYLWFoODE0UEUwa2ZFWkZWdUdBN2FWc1hieno2OHdoZG5aLTJ0NzJEeXEybXA4OFhUWjIwWFpUSkdFSWJDblB0QmxXNUh5cFRIZU40dGxyZFBDRDRMMnFBcWJENlRVZWZySldoWDRhUTlQbFR3TkxsNFZnQWNnMkpxYUp5bVMyaDdzN0UwOUN6QnY3YjhiNEh0ZWdUdzBzMkRRcExmaU9IbGhVVWti?oc=5","date":"2025-12-04","type":"regulatory","source":"PR Newswire","summary":"Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - PR Newswire","headline":"Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNRjQ3VUh4R0ZtbmdYQmJiNDFOSm03MXFtYXl3dG9OWV9sdlNvRlEyWXBhUmxzN3VGWktRWktnQ05tUm1RSDNBSk1mZGgzTlJSMk1kMWxYelNXUE1VdDg2WGlieE8zYzE5Sl9KWHJXYlo5N2dtTUJaWDlrMkdOeFB3ckEzeEN5V2hZNlFvTktxMDNBamFjRFdKZWtramdlR0t0T2FCQmc2OGJiSGJhZGpDdlBkNUVFcWJ2eDV4WksyOGEtQVVSbm1HWEt5WXZ1V29YTDlQTjB4d3JaUnZMOEV3ajg0U1FKTGNHdVc2aFNHWldFYXF0NTlQeWlsajJqWHJPX3NOQU8zVUdEazRUaDFBdlRGLVdYclpZSGdldWY4aWR6dw?oc=5","date":"2025-11-06","type":"trial","source":"PR Newswire","summary":"Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight - PR Newswire","headline":"Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immuno","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQdGlqQkpSMlpFRWt3czlUREdLMkVPUGowT1gtZ2NSVFRwX3BDZUxIMFppaXJqWVJZQ3NEdk9xcC1zSVBLaTVidjdnNEE4MTFDRzVsMlAxWS1yenN0dUxjTkNuMWU0dFQybWlHLVlrVDFpcGVXTUJmdlhmSUtmVjRYQzlOZG5CcVFyUzlXQ1I3QndVLWhLWTJkbnIzdUw5b0xsc0tzbmU1Mm5QWnp2R2xIc1BUZjNkZG5Hb043NzJzZ0xmT1Q1NUdFbmswNGhNX3dZYTctcy1nMVlUY3VKemE3UnNqdXdXVkVKWVVwc2xVYmN4XzUzZjlWVFlYd29LQQ?oc=5","date":"2025-10-07","type":"trial","source":"BioSpace","summary":"Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - BioSpace","headline":"Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbzktb0ZpdUxHb0NIMGN5SjFBWG4zTjRCNmdqbHh4ZndyMjRfNHR6Yk1HNXpBVF93d1BlbzBNNGJfSXNNbnh4cGlxbFFiRmpwMmV4Vkd3WHJycDhfM1ZEZE1PcGVBb1htTVM0OW56cFBlZmVXV3FnZjdWcWtqZXV6aEY4RTFqODFNbUFfNVlOeW9kUm5BQUVhXzhudktUOWcxdUdWVlZtLVA?oc=5","date":"2025-08-06","type":"pipeline","source":"BioSpace","summary":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive - BioSpace","headline":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOaW4zU0poVnpIb2JTODhiOEZ0a1IxRGtKYlhnMDhQelF3eU92RVRDdGdockRkYXQ5MDJLeHAzZzdEVEdhajB5dlg3UWxBanlxTkUyU2JLUWZ2TnBrNkkyMENsOWJKeE1MeHd0YVhfM2lqTTM2dERYV01SdHp0aWZWUlV5MFdlOEpDOVE3aUVTcTdNQQ?oc=5","date":"2025-07-15","type":"trial","source":"Yahoo Finance","summary":"Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - Yahoo Finance","headline":"Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPV1M3NXRQVDYwUnJSS2F0Nlh5LVRJMFlFQjdOMnc3ODczRXVYbmxVRXZCLVFJMDdCRU01ZHZmRkZjcGY1VjlFQWd2WFBuTFNoZ2ZJRTl0Rk9IcTNmUjZyaDE0ZTBHTFJDRFlYYURnT0xRWUlzWUxwX0VoWmZqMThBUVdVS0NnbHAwN2pjRkV2TVJtVS1GWWI4SF9oYnVlUGUya2NjOHpncXBjN0ZpSjV2dk1ST0VYQWhWNTNIdkdLYmU3OEk3UGR3WjNyaFk4aWtfaHF5SUtSZHFJRUdYMW9kMVl5MUVrVU52RVFlRUdQOVE?oc=5","date":"2025-01-29","type":"trial","source":"PR Newswire","summary":"Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight - PR Newswire","headline":"Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQZ0gxNEVCQjFsYmpLdTRPWHU5LTB6TEl2VFhlNi1famIteUlNNDR5cFowMExYeEJPb1lVNjh5UWlQQTJsMDVZVnMwRklIWkxUbmpsQmFaZmozZ3BJcXcteERJVk1ZWkdPTnZYZ0VUejJMTVZJSEh0d2VKSkk1R2ZxSFBRMUNtWmgwXy1CUVhuV2xjRFBoQmFyUHFJa1hxYVJVRXB3anN5a1c3ZV9fNUItRVNNREpDU2NLeXc?oc=5","date":"2024-10-31","type":"pipeline","source":"Reuters","summary":"How Asian pharma suppliers cash in on Ozempic copies - Reuters","headline":"How Asian pharma suppliers cash in on Ozempic copies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPZmlYc0ZXSkhyRkt4WTJaUUcwMWVabWZZWkdjTUJwQl9obUlyVlQ1cHN1WHdKUFhOaTVDU3k3clZSMDJpUWZWcHVjWlBmbUktLUtSeURVYXJyUVp3X1Q4cW42dElVcDRBUnZ4T1ZTbnp2WUEtSHhsdGwxa0ctRzAyQ1NIRzMyanRDV2dsbWplZnV4N0dkeFoyUWtRTlpUOWZZTE9yYzR1UkRfeHUyS0ZqTGVkZmVlV3REM1lTT3c5MHNuVUYtdmV3VV92SDBSMDZaREVaX0pld0c5dTdIaGxTMlhsOGllNWNuWkN0bDhpUC03YUc4QnRYOHN3cFQ2QUNISi1fblBjeGpUOGJjMlFVeUpCZldDT3Z3S3l6ZnVn?oc=5","date":"2024-10-24","type":"trial","source":"BioSpace","summary":"Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace","headline":"Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment an","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPZWEwV0RaRS1hS2w5Q0cxTlBsQ1dzVGJ5X01KbW9YQlQ0WHZfd0dTd1hqaG40dmxpbDRja0drdFRCOVl5RTltT3RwTm9UQ2YxSUQzaFhYNDl5Q2FrNVhZZzBZWHROY3RmNHoxRVdaRHFrWW16YjZITnR1RkVJSmU2VjJFQjhpTGE4aHpkVlJfYWZoQnRsaGhsLTd6WF9HY1gwYXlyRnYweURjTFlTSmJQWGxaOGFoUFJ0OS1DRTFVMWtTU0ZuVWdmV3VtVloxZmtLa2dwWU9wcGxZc3hBaENiSk8wOXpWaXlDUWcwOC1FZUpVMkEwZlE?oc=5","date":"2021-05-06","type":"pipeline","source":"PR Newswire Asia","summary":"Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation - PR Newswire Asia","headline":"Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":1,"phase_2":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}